Navellier & Associates Inc Chroma Dex Corp. Transaction History
Navellier & Associates Inc
- $756 Million
- Q2 2025
A detailed history of Navellier & Associates Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Navellier & Associates Inc holds 152,073 shares of CDXC stock, worth $933,728. This represents 0.12% of its overall portfolio holdings.
Number of Shares
152,073
Previous 125,058
21.6%
Holding current value
$933,728
Previous $862,000
8.24%
% of portfolio
0.12%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
171Shares Held
28.3MCall Options Held
143KPut Options Held
189K-
Vanguard Group Inc Valley Forge, PA3.92MShares$24.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.6MShares$9.84 Million0.01% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.58MShares$9.71 Million8.91% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...